Panitumumab is currently not available.
Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Panitumumab becomes available, please fill out the form below.
*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!
Information about GlobalPharmacyMeds.to
List of countries where we can ship Panitumumab:
Latest news releases on Panitumumab:
Product details for Vectibix; Name: Vectibix: Agency product number: EMEA/H/C/000741: Active substance: panitumumab. International non-proprietary name (INN) or ...
Panitumumab SPECIAL PRECAUTIONS: Caution: • Severe infusion reactions, characterized by anaphylactic reaction, bronchospasm, fever, chills, and hypotension,
Vectibix treats metastatic colorectal cancer that has progressed after treatment with other chemotherapy. Learn about side effects, interactions and indications.
Learn about Vectibix® (panitumumab), a treatment option for wild-type RAS metastatic colorectal cancer. See Prescribing Information and Boxed Warning.
mFOLFOX6 Plus Panitumumab Versus 5-FU/LV Plus Panitumumab After Six Cycles of Frontline mFOLFOX6 Plus Panitumumab: A Randomized Phase II Study of Patients With ...
Panitumumab (ABX-EGF, Vectibix ®) is a fully human recombinant kappa immunoglobulin G (IgG)2 monoclonal antibody with a molecular weight of approximately 147 ...
Each mL of concentrate contains 20 mg panitumumab. Each single-use vial contains either 100 mg of panitumumab in 5 mL, or 400 mg of panitumumab in 20 mL.
Vectibix® (panitumumab) is for treating patients with wild-type RAS metastatic colorectal cancer (cancer that has spread outside of the colon and rectum).